Bisphosphonates are the mainstay of osteoporosis therapy. Extensive clinical evaluation supports their utility in stemming progression of the disease and in reducing fracture risk. In the course ...
Copyright: © 2006 Elsevier Ltd. Published by Elsevier Ltd. Although bisphosphonate-associated osteonecrosis is a serious complication, we should keep in mind the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback